Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BYMicrobiome

Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.

2 more authors
8 affiliations
  1. 1Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  2. 2Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  3. 3Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  4. 4Gutz Technologies, Corvina, CA, USA.
  5. 5Division of Pulmonary and Critical Care Medicine, VA New York Harbor Healthcare System, New York, NY, USA.
  6. 6Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  7. 7Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.
  8. 8Systems Genomics Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. [email protected].

Abstract

Background

The role of the lower airway microbiome in COVID-19-associated mortality remains poorly understood despite evidence implicating secondary pathogens and non-airway commensals. The influence of prior immunosuppression on the lower airway microbiome and its contribution to mortality in mechanically ventilated patients has been largely unexplored. Given that host-microbiome interactions are dynamic, we assessed longitudinal patterns in the respiratory microbiome associated with mortality and immunosuppression status.Results

We conducted longitudinal forecasting, differential abundance, and comparative network analyses of metatranscriptomic data from 604 upper and lower airway samples collected from 243 mechanically ventilated COVID-19 patients to profile key microbial factors associated with immunosuppression and clinical outcome. SARS-CoV-2 was enriched over time in immunosuppressed patients and in both immunosuppressed and immunocompetent patients who died, highlighting the need for aggressive viral infection control early in the disease course. Using longitudinal forecasting and differential abundance analyses, we observed a progressive increase in opportunistic pathogens, such as Staphylococcus aureus and Escherichia coli, among the taxa most predictive of mortality. Concurrently, immunosuppressed individuals exhibited a significant decrease in typical airway commensals alongside a restructuring and marked destabilization of the microbial community compared with their immunocompetent counterparts.Conclusions

These findings indicate that loss of airway microbiome stability in immunosuppressed patients constitutes an independent factor contributing to increased susceptibility to opportunistic pathogens and poor clinical outcomes. Video Abstract.

Related

  1. Re-Du-Ning Alleviates Airway-Intestinal Inflammation of COPD Rats by Regulating Glycerophospholipid Metabolism and Modulating Gut Microbiome
    Yule Wang, Lanyu Cheng, Chunyan Wang +5
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Complex reoperative tracheobronchoplasty for persistent, severe excessive central airway collapse with mesh erosion
    JTCVS techniquesPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Relapsing Polychondritis With Severe Airway Involvement Mimicking Refractory Asthma: A Diagnostic Challenge
    Sruthi Beladev, Manisha Dubey, Seeta Patel
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Severe Intraoperative Airway Leak Revealing Undiagnosed Mounier‐Kuhn Syndrome in an Elderly Patient
    Xuyang Chen, Shuai Miao, Difei Zhou +1
    Clinical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Double‐lumen tube insertion and one‐lung ventilation in Coffin–Siris syndrome: navigating airway challenges in severe scoliosis surgery*
    Talia L. Y. Lim, Simone Misquita
    Anaesthesia ReportsPeer-reviewedLicence not statedFull textSurgery & anaesthesiaPMC
BibTeX
@article{chung2026immunosuppression,
  title = {{Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.}},
  author = {Matthew Chung and Clea R Barnett and Lars Hunger and Imran Sulaiman and Benjamin G Wu and Yonghua Li and Jun-Chieh J Tsay and Shari B Brosnahan and Cecilia J Chung and Luis Angel and Gregg J Silverman and James T Morton and Leopoldo N Segal and Elodie Ghedin},
  journal = {Microbiome},
  year = {2026},
  month = jul,
  doi = {10.1186/s40168-026-02462-1},
  url = {https://europepmc.org/article/MED/42897671},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.
AU  - Matthew Chung
AU  - Clea R Barnett
AU  - Lars Hunger
AU  - Imran Sulaiman
AU  - Benjamin G Wu
AU  - Yonghua Li
AU  - Jun-Chieh J Tsay
AU  - Shari B Brosnahan
AU  - Cecilia J Chung
AU  - Luis Angel
AU  - Gregg J Silverman
AU  - James T Morton
AU  - Leopoldo N Segal
AU  - Elodie Ghedin
PY  - 2026
DA  - 2026/07/01
JO  - Microbiome
DO  - 10.1186/s40168-026-02462-1
UR  - https://europepmc.org/article/MED/42897671
AB  - Background  The role of the lower airway microbiome in COVID-19-associated mortality remains poorly understood despite evidence implicating secondary pathogens and non-airway commensals. The influence of prior immunosuppression on the lower airway microbiome and its contribution to mortality in mechanically ventilated patients has been largely unexplored. Given that host-microbiome interactions are dynamic, we assessed longitudinal patterns in the respiratory microbiome associated with mortality and immunosuppression status.Results  We conducted longitudinal forecasting, differential abundance, and comparative network analyses of metatranscriptomic data from 604 upper and lower airway samples collected from 243 mechanically ventilated COVID-19 patients to profile key microbial factors associated with immunosuppression and clinical outcome. SARS-CoV-2 was enriched over time in immunosuppressed patients and in both immunosuppressed and immunocompetent patients who died, highlighting the need for aggressive viral infection control early in the disease course. Using longitudinal forecasting and differential abundance analyses, we observed a progressive increase in opportunistic pathogens, such as Staphylococcus aureus and Escherichia coli, among the taxa most predictive of mortality. Concurrently, immunosuppressed individuals exhibited a significant decrease in typical airway commensals alongside a restructuring and marked destabilization of the microbial community compared with their immunocompetent counterparts.Conclusions  These findings indicate that loss of airway microbiome stability in immunosuppressed patients constitutes an independent factor contributing to increased susceptibility to opportunistic pathogens and poor clinical outcomes. Video Abstract.
SN  - 2049-2618
ER  -